FENC — FENNEC PHARMACEUTICALS INC.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1211583 ·
Last close
$10.60
Market Cap
$371.89M
52W High
$13.25
52W Low
$5.65
ADV30
218,617
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 17,874,000 | 17,153,000 | 1,737,000 | 1,973,000 | 75,753,000 | 41,249,000 | 33,311,000 |
| Mar 2026 | 15,108,000 | 14,538,000 | -119,000 | 201,000 | 71,822,000 | 40,179,000 | 34,147,000 |
| Dec 2025 | 13,777,000 | 12,013,000 | -2,580,000 | -4,787,000 | 70,551,000 | 36,788,000 | 35,079,000 |
| Sep 2025 | 12,462,000 | 11,802,000 | -201,000 | -638,000 | 49,261,000 | 21,947,000 | 53,753,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-5,776,000
Investing CF
—
Financing CF
$23,280,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.29
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-229,221,000
Inventory
$1,856,000
Receivables
$18,762,000
ST Investments
—
EBIT TTM
$-6,775,000
Pretax Income TTM
$-8,270,000
Interest Exp TTM
$1,495,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$59,221,000
EBITDA
$-1,021,333
Free Cash Flow
$1,070,750
Enterprise Value
$343,087,072
Total Cash
$41,249,000
Total Debt
$0
Shares Out
35,067,159
Trailing EPS
$-0.12
Book Value
$1.21
ROE
-18.6%
ROA
-1.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 44,642,000 | -6,346,000 | -9,741,000 | 70,551,000 | 35,079,000 | 35,472,000 | -12,473,000 |
| Dec 2024 | 47,538,000 | 2,479,000 | -436,000 | 44,946,000 | 50,818,000 | -5,872,000 | 26,980,000 |
| Dec 2023 | 21,252,000 | -13,058,000 | -16,045,000 | 26,864,000 | 38,486,000 | -11,622,000 | -17,143,000 |
| Dec 2022 | 1,535,000 | -22,738,000 | -23,714,000 | 26,939,000 | 29,508,000 | -2,569,000 | -18,058,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.95
Max Pain — expiry 2026-11-20 (volume-derived — Yahoo OI feed degraded)
max pain strike: $15.00 · spot: $10.60 · call volume: 23 · put volume: 455
Expected Move to 2026-11-20:
±$5.59
(52.71%) —
implied range
$5.01 –
$16.19
· ATM straddle on $10.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | $366.61M | $2.98 | — |
| AGEN | AGENUS INC | $384.47M | $8.54 | — |
| ZURA | Zura Bio Ltd | $387.15M | $4.04 | — |
| CABA | Cabaletta Bio, Inc. | $350.96M | $2.07 | — |
| EDIT | Editas Medicine, Inc. | $396.24M | $2.58 | — |
News headlines (Yahoo Finance, 1h cache)
Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026
2026-09-17 11:30 · Yahoo
Fennec Pharmaceuticals Inc (FENC) (Q2 2026) Earnings Call Highlights: Record Sales and ...
2026-08-11 21:02 · Yahoo
Fennec Pharmaceuticals surges 8% as Q2 earnings and revenue beat estimates
2026-08-11 14:20 · Yahoo
Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-08-11 11:01 · Yahoo
Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026
2026-08-05 11:01 · Yahoo
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
2026-06-22 10:00 · Yahoo
Adherex Technologies’ PEDMARK Push Targets Larger AYA Market After Record Quarter
2026-05-23 14:05 · Yahoo
Fennec Announces New Research Supporting Pedmark's Use at ASCO Annual Meeting
2026-05-22 11:21 · Yahoo
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
2026-05-21 22:01 · Yahoo
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-05-18 20:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.